myo-inositol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases gestational diabetes mellitus incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“For the mother, supplementation with myo-inositol was associated with a reduction in the incidence of gestational diabetes compared with control (risk ratio (RR) 0.43, 95% confidence interval (CI) 0.29 to 0.64; three trials; n = 502 women).”
Quoted verbatim from Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.. - Study
- meta-analysis
- Participants
- 502
- Population
- Pregnant women without pre-existing diabetes, pooled from three randomised trials conducted in Italy
Effect 0.43 risk ratio, 95% CI 0.29 to 0.64
Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.2015PMID:26678256Permalink
Keep reading
- Everything the graph holds on myo-inositol
- Every compound studied against Gestational diabetes mellitus incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4Q22QJGXA724SFA49J5C0KJ